MedPath

To assess the Artificial Intelligence Software in detection of Diabetic Retinopathy

Not Applicable
Conditions
Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
Registration Number
CTRI/2020/03/024000
Lead Sponsor
Dr S Sivaranjani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All the diabetic patients visiting the DR screening camps with pupil size 3 mm or more, cataract with grade senile immature cataract with nuclear sclerosis II (NSII) and with clear cornea.

Exclusion Criteria

Patients with macular or leucomatous corneal opacity, cataract with grade more than senile immature cataract with nuclear sclerosis II.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the accuracy of grading done by Artificial IntelligenceTimepoint: Once the recruitment is completed, the images will be sent to Retina Specialist and assessed. Time point will be 3 months.
Secondary Outcome Measures
NameTimeMethod
To assess the number of patients with Diabetic Retinopathy in patients who come for a Diabetic Retinopathy camp.Timepoint: By the end of recruitment - 3 months
© Copyright 2025. All Rights Reserved by MedPath